Table 1.
No evidence of disease | Primary disease I (presurgery) |
Primary disease II (postsurgery) |
Metastatic disease | |
---|---|---|---|---|
No of patients | 10 | 14 | 12 | 23 |
Age (mean) | 62.9 | 59.1 | 53.8 | 53.7 |
Premenopausal | 1 | 5 | 5 | 8 |
Postmenopausal | 9 | 9 | 7 | 15 |
Stage 1 | 6 | 0 | 1 | 0 |
Stage II | 3 | 5 | 7 | 0 |
Stage III | 1 | 9 | 4 | 0 |
Stage IV | 0 | 0 | 0 | 23 |
Tumor size 1–1.9 cm | 6 | 0 | 2 | 1 |
Tumor size 2–3.9 cm | 1 | 3 | 7 | 2 |
Tumor size >4 cm | 1 | 11 | 3 | 14 |
Unknown | 2 | 0 | 0 | 6 |
Grade 1 or 2 | 3 | 5 | 3 | 6 |
Grade 3 | 4 | 8 | 7 | 12 |
Unknown | 3 | 1 | 2 | 5 |
Lymph node 0 | 7 | 3 | 6 | 4 |
Lymph nodes 1–3 | 3 | 11 | 6 | 15 |
Unknown | 0 | 0 | 0 | 4 |
Estrogen receptor + | 6 | 7 | 8 | 15 |
Estrogen receptor − | 1 | 7 | 4 | 8 |
Unknown | 3 | 0 | 0 | 0 |
Progesterone receptor + | 5 | 7 | 8 | 10 |
Progesterone receptor − | 2 | 7 | 4 | 13 |
Unknown | 3 | 0 | 0 | 0 |
Her2/neu + | 4 | 12 | 8 | 19 |
Her2/neu − | 2 | 1 | 4 | 4 |
Unknown | 4 | 1 | 0 | 0 |